6Schriber J, Milk B, Shaw D, et al. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation. Bone Marrow Transplant, 1999, 24: 1311-1314.
2Ramírez-de-la-Piscina P,Estrada S,Calderón R.Budd-Chiari syndrome secondary to infl ammatory pseudotumor of the liver:report of a case with a 10-year follow-up. Revista Espanola de Enfermedades Digestivas . 2013
3Wu JS,Poon WT,Ma CK,et al.Budd-Chiari syndrome secondary to toxic pyrrolizidine alkaloid exposure. Hong Kong Medical Journal . 2013
4Darwish Murad S,A Plessier,M Hernandez-Guerra,F Fabris,CE Eapen,MJ Bahr,J Trebicka,I Morard,L Lasser,J Heller,A Hadengue,P Langlet,H Miranda,M Primignani,E Elias,FW Leebeek,FR Rosendaal,JC Garcia-Pagan,DC Valla,HL Janssen,EN-Vie (Europ.Etiology, management, and outcome of the Budd-Chiari syndrome. Annals of Internal Medicine . 2009
5Jun Muratsu,Atsuyuki Morishima,Kazuhiro Mizoguchi,Keiji Ataka,Hiroshi Yamamoto,Xinping Fan,Toshiyuki Miyata,Katsuhiko Sakaguchi,Yasuhiko Sugawara.??Budd-Chiari Syndrome with Multiple Thrombi due to a Familial Arg42Ser Mutation in the Protein C Gene(J)Case Reports in Medicine . 2013
